Lymphocytes in Endometriosis

American Journal of Reproductive Immunology

Volumn 65, Issue 1, 2011, Pages 1-10

  Osuga, Yutaka ^a   Koga, Kaori ^a   Hirota, Yasushi ^a   Hirata, Testuya ^a   Yoshino, Osamu ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

B lymphocyte; Endometriosis; Natural killer cell; T lymphocyte

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; GONADORELIN DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ENDOMETRIOSIS; HORMONAL THERAPY; HUMAN; IMMUNOPATHOGENESIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ENDOMETRIOSIS; FEMALE; HUMANS; LYMPHOCYTES;

EID: 78650159134     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00887.x     Document Type: Review

References (86)

1. Momoeda M, Taketani Y, Terakawa N, Hoshiai H, Tanaka K, Tsutsumi O, Osuga Y, Maruyama M, Harada T, Obata K, Hayashi K: Is endometriosis really associated with pain? Gynecol Obstet Invest 2002;54(Suppl. 1):18-21; discussion 21-13.
2. Osuga Y, Koga K, Tsutsumi O, Yano T, Maruyama M, Kugu K, Momoeda M, Taketani Y: Role of laparoscopy in the treatment of endometriosis-associated infertility. Gynecol Obstet Invest 2002; 53(Suppl 1):33-39.
3. Osuga Y: Novel therapeutic strategies for endometriosis: a pathophysiological perspective. Gynecol Obstet Invest 2008; 66(Suppl 1):3-9.
4. Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, Masuzaki H: Immunopathogenesis of pelvic endometriosis: role of hepatocyte growth factor, macrophages and ovarian steroids. Am J Reprod Immunol 2008; 60:383-404.
5. Santanam N, Murphy AA, Parthasarathy S: Macrophages, oxidation, and endometriosis. Ann NY Acad Sci 2002; 955:183-198.
6. Dmowski WP, Steele RW, Baker GF: Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981; 141:377-383.
7. Helvacioglu A, Aksel S, Peterson RD: Endometriosis and autologous lymphocyte activation by endometrial cells. Are lymphocytes or endometrial cell defects responsible?. J Reprod Med 1997; 42:71-75.
8. Gilmore SM, Aksel S, Hoff C, Peterson RD: In vitro lymphocyte activity in women with endometriosis - an altered immune response? Fertil Steril 1992; 58:1148-1152.
9. Steele RW, Dmowski WP, Marmer DJ: Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984; 6:33-36.
10. Melioli G, Semino C, Semino A, Venturini PL, Ragni N: Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis. Am J Reprod Immunol 1993; 30:218-227.
11. Velasco I, Quereda F, Bermejo R, Campos A, Acien P: Intraperitoneal recombinant interleukin-2 activates leukocytes in rat endometriosis. J Reprod Immunol 2007; 74:124-132.
12. Selam B, Kayisli UA, Akbas GE, Basar M, Arici A: Regulation of FAS ligand expression by chemokine ligand 2 in human endometrial cells. Biol Reprod 2006; 75:203-209.
13. Selam B, Kayisli UA, Garcia-Velasco JA, Akbas GE, Arici A: Regulation of fas ligand expression by IL-8 in human endometrium. J Clin Endocrinol Metab 2002; 87:3921-3927.
14. Ohata Y, Harada T, Miyakoda H, Taniguchi F, Iwabe T, Terakawa N: Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril 2008; 90:994-999.
15. Iwabe T, Harada T, Tsudo T, Tanikawa M, Onohara Y, Terakawa N: Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998; 69:924-930.
16. Arici A, Tazuke SI, Kliman HJ, Olive DL: Endocrinology and paracrinology: interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996; 2:40-45.
17. Akoum A, Lemay A, McColl S, Turcot-Lemay L, Maheux R: Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1996; 66:17-23.
18. Agic A, Djalali S, Wolfler MM, Halis G, Diedrich K, Hornung D: Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci 2008; 15:906-911.
19. Garcia-Velasco JA, Mulayim N, Kayisli UA, Arici A: Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertil Steril 2002; 78:855-859.
20. Tariverdian N, Siedentopf F, Rucke M, Blois SM, Klapp BF, Kentenich H, Arck PC: Intraperitoneal immune cell status in infertile women with and without endometriosis. J Reprod Immunol 2009; 80:80-90.
21. Gallinelli A, Chiossi G, Giannella L, Marsella T, Genazzani AD, Volpe A: Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets. Gynecol Endocrinol 2004; 18:144-151.
22. Oosterlynck DJ, Meuleman C, Lacquet FA, Waer M, Koninckx PR: Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis. Am J Reprod Immunol 1994; 31:25-31.
23. Hill JA, Faris HM, Schiff I, Anderson DJ: Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis. Fertil Steril 1988; 50:216-222.
24. Ho HN, Chao KH, Chen HF, Wu MY, Yang YS, Lee TY: Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod 1995; 10:2671-2675.
25. Lee KS, Baek DW, Kim KH, Shin BS, Lee DH, Kim JW, Hong YS, Bae YS, Kwak JY: IL-10-dependent down-regulation of MHC class II expression level on monocytes by peritoneal fluid from endometriosis patients. Int Immunopharmacol 2005; 5:1699-1712.
26. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Yang YS: Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod 1997; 12:2528-2533.
27. Oosterlynck DJ, Cornillie FJ, Waer M, Koninckx PR: Immunohistochemical characterization of leucocyte subpopulations in endometriotic lesions. Arch Gynecol Obstet 1993; 253:197-206.
28. Jones RK, Bulmer JN, Searle RF: Immunohistochemical characterization of stromal leukocytes in ovarian endometriosis: comparison of eutopic and ectopic endometrium with normal endometrium. Fertil Steril 1996; 66:81-89.
29. Witz CA, Montoya IA, Dey TD, Schenken RS: Characterization of lymphocyte subpopulations and T cell activation in endometriosis. Am J Reprod Immunol 1994; 32:173-179.
30. Fernandez-Shaw S, Clarke MT, Hicks B, Naish CE, Barlow DH, Starkey PM: Bone marrow-derived cell populations in uterine and ectopic endometrium. Hum Reprod 1995; 10:2285-2289.
31. Ota H, Igarashi S, Tanaka T: Expression of gamma delta T cells and adhesion molecules in endometriotic tissue in patients with endometriosis and adenomyosis. Am J Reprod Immunol 1996; 35:477-482.
32. Antsiferova YS, Sotnikova NY, Posiseeva LV, Shor AL: Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 2005; 84:1705-1711.
33. Hsu CC, Yang BC, Wu MH, Huang KE: Enhanced interleukin-4 expression in patients with endometriosis. Fertil Steril 1997; 67:1059-1064.
34. Szyllo K, Tchorzewski H, Banasik M, Glowacka E, Lewkowicz P, Kamer-Bartosinska A: The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators Inflamm 2003; 12:131-138.
35. Gmyrek GB, Sieradzka U, Goluda M, Gabrys M, Sozanski R, Jerzak M, Zbyryt I, Chrobak A, Chelmonska-Soyta A: Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis. Immunol Invest 2008; 37:43-61.
36. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Chen HF, Yang YS: Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. Am J Obstet Gynecol 1996; 175:1236-1241.
37. Wu M-H, Yang B-C, Hsu C-C, Lee Y-C, Huang K-E: The expression of soluble intercellular adhesion molecule-1 in endometriosis. Fertil Steril 1998; 70:1139-1142.
38. Podgaec S, Abrao MS, Dias Jr JA, Rizzo LV, De Oliveira RM, Baracat EC: Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 2007; 22:1373-1379.
39. Siedentopf F, Tariverdian N, Rucke M, Kentenich H, Arck PC: Immune status, psychosocial distress and reduced quality of life in infertile patients with endometriosis. Am J Reprod Immunol 2008; 60:449-461.
40. OuYang Z, Hirota Y, Osuga Y, Hamasaki K, Hasegawa A, Tajima T, Hirata T, Koga K, Yoshino O, Harada M, Takemura Y, Nose E, Yano T, Taketani Y: Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol 2008; 173:463-469.
41. Ouyang Z, Osuga Y, Hirota Y, Hirata T, Yoshino O, Koga K, Yano T, Taketani Y: Interleukin-4 induces expression of eotaxin in endometriotic stromal cells. Fertil Steril. in press.
42. Miossec P, Korn T, Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-898.
43. Hirata T, Osuga Y, Hamasaki K, Yoshino O, Ito M, Hasegawa A, Takemura Y, Hirota Y, Nose E, Morimoto C, Harada M, Koga K, Tajima T, Saito S, Yano T, Taketani Y: Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 2008; 149:1260-1267.
44. Velasco I, Acien P, Campos A, Acien MI, Ruiz-Macia E: Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression. J Reprod Immunol 2010; 84:199-205.
45. Feuerer M, Hill JA, Mathis D, Benoist C: Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 2009; 10:689-695.
46. Berbic M, Hey-Cunningham AJ, Ng C, Tokushige N, Ganewatta S, Markham R, Russell P, Fraser IS: The role of Foxp3+ regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum Reprod 2010; 25:900-907.
47. Hsu CC, Lin YS, Wang ST, Huang KE: Immunomodulation in women with endometriosis receiving GnRH agonist. Obstet Gynecol 1997; 89:993-998.
48. Wu MY, Chao KH, Chen SU, Chen HF, Yang YS, Huang SC, Ho HN: The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment. Am J Reprod Immunol 1996; 35:510-516.
49. D'Hooghe TM, Hill JA, Oosterlynck DJ, Koninckx PR, Bambra CS: Effect of endometriosis on white blood cell subpopulations in peripheral blood and peritoneal fluid of baboons. Hum Reprod 1996; 11:1736-1740.
50. Startseva NV: [Clinical immunological aspects of genital endometriosis]. Akush Ginekol (Mosk) 1980; 3:23-26.
51. Weed JC, Arquembourg PC: Endometriosis: can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol 1980; 23:885-893.
52. Wild RA, Shivers CA: Antiendometrial antibodies in patients with endometriosis. Am J Reprod Immunol Microbiol 1985; 8:84-86.
53. Fernandez-Shaw S, Hicks BR, Yudkin PL, Kennedy S, Barlow DH, Starkey PM: Anti-endometrial and anti-endothelial auto-antibodies in women with endometriosis. Hum Reprod 1993; 8:310-315.
54. Kennedy SH, Starkey PM, Sargent IL, Hicks BR, Barlow DH: Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin. Obstet Gynecol 1990; 75:914-918.
55. Wild RA, Satyaswaroop PG, Shivers AC: Epithelial localization of antiendometrial antibodies associated with endometriosis. Am J Reprod Immunol Microbiol 1987; 13:62-65.
56. Bohler HC, Gercel-Taylor C, Lessey BA, Taylor DD: Endometriosis markers: immunologic alterations as diagnostic indicators for endometriosis. Reprod Sci 2007; 14:595-604.
57. Mathur SP: Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 2000; 44:89-95.
58. Mathur S, Garza DE, Smith LF: Endometrial autoantigens eliciting immunoglobulin (Ig)G, IgA, and IgM responses in endometriosis. Fertil Steril 1990; 54:56-63.
59. Mathur S, Butler WJ, Chihal HJ, Isaacson KB, Gleicher N: Target antigen(s) in endometrial autoimmunity of endometriosis. Autoimmunity 1995; 20:211-222.
60. Yeaman GR, Collins JE, Lang GA: Autoantibody responses to carbohydrate epitopes in endometriosis. Ann NY Acad Sci 2002; 955:174-182.
61. Gleicher N, El-Roeiy A, Confino E, Friberg J: Is endometriosis an autoimmune disease? Obstet Gynecol 1987; 70:115-122.
62. Badawy SZ, Cuenca V, Stitzel A, Tice D: Immune rosettes of T and B lymphocytes in infertile women with endometriosis. J Reprod Med 1987; 32:194-197.
63. Gagne D, Rivard M, Page M, Shazand K, Hugo P, Gosselin D: Blood leukocyte subsets are modulated in patients with endometriosis. Fertil Steril 2003; 80:43-53.
64. Badawy SZ, Cuenca V, Kaufman L, Stitzel A, Thompson M: The regulation of immunoglobulin production by B cells in patients with endometriosis. Fertil Steril 1989; 51:770-773.
65. Odukoya OA, Bansal A, Wilson AP, Weetman AP, Cooke ID: Serum-soluble CD23 in patients with endometriosis and the effect of treatment with danazol and leuprolide acetate depot injection. Hum Reprod 1995; 10:942-946.
66. Gebel HM, Braun DP, Rotman C, Rana N, Dmowski WP: Mitogen induced production of polyclonal IgG is decreased in women with severe endometriosis. Am J Reprod Immunol 1993; 29:124-130.
67. Chishima F, Hayakawa S, Hirata Y, Nagai N, Kanaeda T, Tsubata K, Satoh K: Peritoneal and peripheral B-1-cell populations in patients with endometriosis. J Obstet Gynaecol Res 2000; 26:141-149.
68. Hever A, Roth RB, Hevezi P, Marin ME, Acosta JA, Acosta H, Rojas J, Herrera R, Grigoriadis D, White E, Conlon PJ, Maki RA, Zlotnik A: Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci USA 2007; 104:12451-12456.
69. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR: Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991; 56:45-51.
70. Vigano P, Vercellini P, Di Blasio AM, Colombo A, Candiani GB, Vignali M: Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril 1991; 56:894-899.
71. Garzetti GG, Ciavattini A, Provinciali M, Fabris N, Cignitti M, Romanini C: Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. Obstet Gynecol 1993; 81:665-668.
72. Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR: The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992; 58:290-295.
73. Tanaka E, Sendo F, Kawagoe S, Hiroi M: Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 1992; 34:27-30.
74. Kanzaki H, Wang HS, Kariya M, Mori T: Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol 1992; 167:257-261.
75. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR, Vandeputte M: Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol 1993; 82:206-212.
76. Mazzeo D, Vigano P, Di Blasio AM, Sinigaglia F, Vignali M, Panina-Bordignon P: Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. J Clin Endocrinol Metab 1998; 83:911-916.
77. Hirata J, Kikuchi Y, Imaizumi E, Tode T, Nagata I: Endometriotic tissues produce immunosuppressive factors. Gynecol Obstet Invest 1994; 37:43-47.
78. Somigliana E, Vigano P, Gaffuri B, Candiani M, Busacca M, Di Blasio AM, Vignali M: Modulation of NK cell lytic function by endometrial secretory factors: potential role in endometriosis. Am J Reprod Immunol 1996; 36:295-300.
79. Wu MY, Yang JH, Chao KH, Hwang JL, Yang YS, Ho HN: Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril 2000; 74:1187-1191.
80. Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T: Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 2002; 77:297-302.
81. Maeda N, Izumiya C, Oguri H, Kusume T, Yamamoto Y, Fukaya T: Aberrant expression of intercellular adhesion molecule-1 and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis. Fertil Steril 2002; 77:679-683.
82. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR: CO2-laser excision of endometriosis does not improve the decreased natural killer activity. Acta Obstet Gynecol Scand 1994; 73:333-337.
83. Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano G, Fabris N: Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: positive modulation on natural killer activity. Obstet Gynecol 1996; 88:234-240.
84. Umesaki N, Tanaka T, Miyama M, Mizuno K, Kawamura N, Ogita S: Increased natural killer cell activities in patients treated with gonadotropin releasing hormone agonist. Gynecol Obstet Invest 1999; 48:66-68.
85. Katsuki Y, Takano Y, Futamura Y, Shibutani Y, Aoki D, Udagawa Y, Nozawa S: Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. Eur J Endocrinol 1998; 138:216-226.
86. Matsubayashi H, Makino T, Iwasaki K, Maruyama T, Ozawa N, Hosokawa T, Someya K, Nozawa S: Leukocyte subpopulation changes in rats with autotransplanted endometrium and the effect of danazol. Am J Reprod Immunol 1995; 33:301-314.